BAKER DOUGLAS P
SEC CIK 1028775 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | CFO | 44.8K | — | $5.97M | 17 | 2021-07-08 | 2021-10-05 |
Most active insiders at OPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Silvestro Stephen L | CEO | — | $30.4K |
| 2 | Stelmakh Edward | Chief Fin, Strat Off | — | $18.8K |
| 3 | Presti Mariyamma Varghese | Dir | — | — |
| 4 | Merrell Brendan W. | COO | — | — |
| 5 | D'Silva Andrew J. | Chief Business Off | — | — |
| 6 | Greco Theresa | Chief Commercial Off | — | — |
| 7 | Besch Doug | Chief Product, Tech Off | — | — |
| 8 | Odence-Ford Marion | Chief Legal, Admin Off | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | Vos Ellen O'Connor | Dir | — | — |
BAKER DOUGLAS P made no open-market trades at OPRX in the last 12 months.
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-10-05 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | +10.0K | 44.8K | +29% | +$75.1K |
| DM | 2021-10-05 | 2021-10-05 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale+OE | $82.88 | -14.0K | 34.8K | -29% | -$1.16M |
| 2021-09-29 | 2021-09-28 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $74.66 | -2,000 | 38.8K | -5% | -$149.3K | |
| 2021-09-22 | 2021-09-21 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $70.59 | -4,000 | 40.8K | -9% | -$282.4K | |
| 2021-09-15 | 2021-09-14 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $65.57 | -3,768 | 44.8K | -8% | -$247.1K | |
| DM | 2021-09-09 | 2021-09-07+ | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale+OE | $67.85 | -12.2K | 48.6K | -20% | -$829.9K |
| D | 2021-09-09 | 2021-09-08 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | +10.0K | 58.6K | +21% | +$75.1K |
| 2021-09-02 | 2021-08-31 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $66.62 | -4,000 | 50.8K | -7% | -$266.5K | |
| M | 2021-08-24 | 2021-08-20+ | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $59.81 | -9,000 | 54.8K | -14% | -$538.2K |
| M | 2021-08-17 | 2021-08-13+ | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $61.13 | -9,000 | 63.8K | -12% | -$550.2K |
| DM | 2021-08-10 | 2021-08-09+ | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale+OE | $64.34 | -12.0K | 64.8K | -16% | -$772.1K |
| D | 2021-08-10 | 2021-08-09 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | +10.0K | 74.8K | +15% | +$75.1K |
| 2021-08-03 | 2021-08-03 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $54.93 | -2,000 | 74.8K | -3% | -$109.9K | |
| 2021-07-28 | 2021-07-27 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $52.58 | -3,000 | 76.8K | -4% | -$157.7K | |
| 2021-07-21 | 2021-07-20 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale | $50.90 | -3,000 | 79.8K | -4% | -$152.7K | |
| D | 2021-07-09 | 2021-07-08 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | M - OptEx | $2.46 | +13.4K | 82.8K | +19% | +$33.1K |
| D | 2021-07-09 | 2021-07-08 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CFO | S - Sale+OE | $56.05 | -13.4K | 69.4K | -16% | -$753.0K |
Purchase Sale Sale after option exercise All abbreviations